Ensign Peak Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-194,887
Closed -$63.5M 1752
2024
Q1
$63.5M Sell
194,887
-123,455
-39% -$30.3M 0.12% 165
2023
Q4
$60.7M Buy
318,342
+307,362
+2,799% +$58.1M 0.12% 155
2023
Q3
$2.19M Sell
10,980
-505
-4% -$119K ﹤0.01% 808
2023
Q2
$3.28M Buy
11,485
+505
+5% +$140K 0.01% 710
2023
Q1
$2.38M Buy
10,980
+1,150
+12% +$224K 0.01% 779
2022
Q4
$2.02M Buy
9,830
+750
+8% +$190K ﹤0.01% 813
2022
Q3
$2.52M Hold
9,080
0.01% 704
2022
Q2
$1.74M Buy
9,080
+1,450
+19% +$256K ﹤0.01% 858
2022
Q1
$1.58M Hold
7,630
﹤0.01% 974
2021
Q4
$1.36M Buy
+7,630
New +$1.5M ﹤0.01% 1123

Other funds holding SWAV

Ensign Peak Advisors's SWAV Position: Q2 2024 in Review

Ensign Peak Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 194,887 shares — an estimated $63.5M sold.

Ensign Peak Advisors first reported a position in SWAV in Q4 2021 and held it in 10 quarters. The position peaked at $63.5M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Ensign Peak Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 194,887 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $63.5M.
  • Ensign Peak Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Ensign Peak Advisors's Shockwave Medical, Inc. Common Stock position peaked at $63.5M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.